CARDIFF ONCOLOGY, INC. Long-term Debt and Lease Obligation
CARDIFF ONCOLOGY, INC. (CRDF) had Long-term Debt and Lease Obligation of $0 as of 2017-12-31, per its 10-K filed 2018-02-26.
Discontinued › Balance Sheet › Liabilities › Liabilities, Noncurrent › Long-Term Debt and Lease Obligation
us-gaap:LongTermDebtAndCapitalLeaseObligations · last filed 2018-02-26
- 2017-12-31: Long-term Debt and Lease Obligation $0.00.
- 2017-09-30: Long-term Debt and Lease Obligation $0.00.
- 2017-06-30: Long-term Debt and Lease Obligation $0.00.
- 2017-03-31: Long-term Debt and Lease Obligation $12.70M.
| Period end | Long-term Debt and Lease Obligation |
|---|---|
| 2017-12-31 | $0.00 10-K · filed 2018-02-26 |
| 2017-09-30 | $0.00 10-Q · filed 2017-11-09 |
| 2017-06-30 | $0.00 10-Q · filed 2017-08-09 |
| 2017-03-31 | $12.70M 10-Q · filed 2017-05-10 |
| 2016-12-31 | $14.18M 10-K · filed 2018-02-26 |
| 2016-09-30 | $15.60M 10-Q · filed 2016-11-09 |
| 2016-06-30 | $9.03M 10-Q · filed 2016-08-04 |
| 2016-03-31 | $10.37M 10-Q · filed 2016-05-10 |
| 2015-12-31 | $11.25M 10-K · filed 2017-03-15 |
| 2015-09-30 | $11.52M 10-Q · filed 2015-11-09 |
| 2015-06-30 | $12.88M 10-Q · filed 2015-08-10 |
| 2015-03-31 | $12.01M 10-Q · filed 2015-05-05 |
| 2014-12-31 | $13.05M 10-K · filed 2016-03-10 |
| 2014-09-30 | $13.98M 10-Q · filed 2014-11-06 |
| 2014-06-30 | $14.70M 10-Q · filed 2014-08-07 |
| 2014-03-31 | $274.85K 10-Q · filed 2014-05-12 |
| 2013-12-31 | $323.00K 10-K · filed 2015-03-12 |
| 2013-09-30 | $370.43K 10-Q · filed 2013-11-14 |
| 2013-06-30 | $252.18K 10-Q · filed 2013-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |
| LENZ Therapeutics, Inc. (LENZ) | United States | $0.117B | -1.41 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B |